CLINICAL_TRIALS
research
· 2025-08-08
Clinical Trial Update: Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage [NA]
Summary
A pivotal, prospective, multi-centre, single-arm clinical trial sponsored by Baymatob Operations Pty Ltd to evaluate the safety and effectiveness of Oli for ide…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Baymatob Operations Pty Ltd | Conditions: Post Partum Haemorrhage, Maternal Care Patterns | NA | Status: RECRUITING